ArticleRadiology case reports2026
A case report of concurrent dermatofibrosarcoma protuberans and papillary thyroid carcinoma: Diagnostic and therapeutic challenges.
Article in Radiology case reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The simultaneous presence of more than 1 primary malignancy is not usual and is both a challenge in diagnosis and management. We are presenting a 47-year-old male with both papillary thyroid carcinoma (PTC) and dermatofibrosarcoma protuberans (DFSP). The patient presented with a progressively enlarging scalp tumor and palpable cervical adenopathy that prompted further imaging and biopsy. Histopathological examination identified DFSP with CD34 immunopositivity, a locally aggressive tumor with a tendency for recurrences, and PTC with lymphatic invasion and microscopic extrathyroidal extension. Due to the complexity of this diagnosis, a tailored treatment plan had to be formulated. The patient underwent neoadjuvant imatinib therapy for reduction of tumor in DFSP and subsequent total thyroidectomy and radioactive iodine therapy for PTC. The current case highlights the need for integrative and multidisciplinary management of synchronous malignancies with distinctive biological behaviors. Advanced imaging with molecular diagnostics and individualized treatment modalities is essential in optimizing patient outcomes. Increased research into pathogenic mechanisms of such unusual malignancy associations is needed to enhance future management.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.